Reduced angiogenesis and tumor progression in gelatinase A-deficient mice

Cancer Research

Volumn 58, Issue 5, 1998, Pages 1048-1051

  Itoh, Takeshi ^a   Tanioka, Masatoshi ^a   Yoshida, Hiroshi ^a   Yoshioka, Takayuki ^a   Nishimoto, Hirofumi ^a   Itohara, Shigeyoshi ^b  

^a SHIONOGI AND CO LTD   (Japan)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; GELATINASE A; GELATINASE INHIBITOR;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INHIBITION; CANCER INVASION; CONTROLLED STUDY; LEWIS CARCINOMA; MELANOMA CELL; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; TUMOR GROWTH; TUMOR VOLUME;

ANIMALS; CELL DIVISION; CELL MOVEMENT; GELATINASES; HUMANS; MATRIX METALLOPROTEINASE 2; MELANOMA, EXPERIMENTAL; METALLOENDOPEPTIDASES; MICE; MICE, MUTANT STRAINS; NEOVASCULARIZATION, PATHOLOGIC;

EID: 0032031861     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Stetler-Stevenson, W. G., Krutzsch, H. C., Wacher, M. P., Margulies, I. M. K., and Liotta, L. A. The activation of human type IV collagenase proenzyme. J. Biol. Chem., 264: 1353-1356, 1989.
2. Docherty, A. J. P., Lyons, A., Smith, B. J., Wright, E. M., Stephens, P. E., and Harris, T. J. R. Sequence of human tissue inhibitor of metalloproteinases and its identity to erythroid-potentiating activity. Nature (Lond.), 318: 66-69, 1985.
3. Stetler-Stevenson, W. G., Krutzsch, H. C., and Liotta, L. A. Tissue inhibitor of metalloproteinase (TIMP-2). J. Biol. Chem., 264: 17374-17378, 1989.
4. Liotta, L. A., Tryggvason, K., Garbisa, S., Hart, I., Foltz, C. M., and Shafie, S. Metastatic potential correlates with enzymatic degradation of basement membrane collagen. Nature (Lond.), 284: 67-68, 1980.
5. Liotta, L. A. Tumor invasion and metastases: role of the extracellular matrix: Rhoads Memorial Award Lecture. Cancer Res., 46: 1-7, 1986.
6. Moses, M. A., Sudhalter, J., and Langer, R. Identification of an inhibitor of neovascularization from cartilage. Science (Washington DC), 248: 1408-1410, 1990.
7. Johnson, M. D., Kim, H-R. C., Chesler, L., Tsao-Wu, G., Bouck, N., and Polverini, P. J. Inhibition of angiogenesis by tissue inhibitor of metalloproteinase. J. Cell. Physiol. 160: 194-202, 1994.
8. Unemori, E. N., Bouhana, K. S., and Werb, Z. Vectorial secretion of extracellular matrix proteins, matrix-degrading proteinases, and tissue inhibitor of metalloproteinases by endothelial cells. J. Biol. Chem., 265: 445-451, 1990.
9. Sato, H., Takino, T., Okada, Y., Cao, J., Shinagawa, A., Yamamoto, E., and Seiki, M. A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature (Lond.), 370: 61-65, 1994.
10. Brooks, P. C., Strömblad, S., Sanders, L. C., von Schalscha, T. L., Aimes, R. T., Stetler-Stevenson, W. G., Quigley, J. P., and Cheresh, D. A. Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin αvβ3. Cell, 85: 683-693, 1996.
11. Itoh, T., Ikeda, T., Gomi, H., Nakao, S. Suzuki, T., and Itohara, S. Unaltered secretion of β-amyloid precursor protein in gelatinase A (matrix metalloproteinase 2)-deficient mice. J. Biol. Chem., 272: 22389-22392, 1997.
12. Hart, I. R. The selection and characterization of an invasive variant of the B16 melanoma. Am. J. Pathol., 97: 587-600, 1979.
13. Iwahana, M., Nakayama, Y., Tanaka, N. G., Goryo, M., and Okada, K. Quantification of tumour-induced angiogenesis by image analysis. Int. J. Exp. Pathol., 77: 109-114, 1996.
14. Kato, Y., Nakayama, Y., Umeda, M., and Miyazaki, K. Induction of 103-kDa gelatinase/type IV collagenase by acidic culture conditions in mouse metastatic melanoma cell lines. J. Biol. Chem., 267: 11424-11430, 1992.
15. Brodt, P., Reich, R., Moroz, L. A., and Chambers, A. F. Differences in the repertoires of basement membrane degrading enzymes in two carcinoma sublines with distinct patterns of site-selective metastasis. Biochim. Biophys. Acta, 1139: 77-83, 1992.
16. Kim, K. J., Li, B., Winer, J., Aramanini, M., Gillett, N., Phillips, H. S., and Ferrara, N. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumor growth in vivo. Nature (Lond.), 362: 841-844, 1993.
17. Millauer, B., Shawver, L. K., Plate, K. H., Risau, W., and Ullrich, A. Glioblastoma growth inhibited in vivo by a dominant-negative FLK-1 mutant. Nature (Lond.), 367: 576-579, 1994.
18. Parangi, S., O'Reilly, M., Christofori, G., Holmgren, L., Grosfeld, J. Folkman, J., and Hanahan, D. Antiangiogenic therapy of transgenic mice impairs de novo tumor growth. Proc. Natl. Acad. Sci. USA, 93: 2002-2007, 1996.
19. Tanaka, T., Manome, Y., Wen, P., Kufe, D. W., and Fine, H. A. Viral vector-mediated transduction of a modified platelet factor 4 cDNA inhibits angiogenesis and tumor growth. Nat. Med., 3: 437-442, 1997.
20. Fisher, C., Gilbertson-Beadline, S., Powers, E. A., Petzold, G. Poorman, R., and Mitchell, M. A. Interstitial collagenase is required for angiogenesis in vitro. Dev. Biol., 162: 499-510, 1994.